EUS- and US- Guided Biopsy for Pancreatic Lesion

Tian'an Jiang

Status: Not yet enrolling

Conditions: Pancreatic Cancer

Treatments: Other: sampling tissue

Study type: Observational

Funder types: Other

Identifiers

NCT07138976

Pancreatic biopsy-PSM

Details and patient eligibility

About

Endoscopic ultrasound (EUS) and ultrasound (US) are the two primary imaging modalities used to guide pancreatic needle biopsy. This study aimed to compare the diagnostic performance and complications associated with EUS- and US-guided pancreatic biopsies.

Enrollment: 2,517 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Between January 2017 and December 2023, 2663 consecutive patients with focal pancreatic disease underwent 2729 procedures for pancreatic tissue acquisition from focal pancreatic lesions at seven university teaching hospitals in China.

Exclusion criteria

• Patients were excluded from the study if they had less than 12 months of follow-up, were lost to follow-up, had incomplete follow-up data, or underwent intraoperative biopsy or fluid aspiration.

Trial design